Memantine in Systemic Lupus Erythematosus: A Randomized, Double-Blind Placebo-Controlled Trial

Seminars in Arthritis and Rheumatism

Volumn 41, Issue 2, 2011, Pages 194-202

  Petri, Michelle ^a   Naqibuddin, Mohammad ^a   Sampedro, Margaret ^a   Omdal, Roald ^b   Carson, Kathryn A ^c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STAVANGER UNIVERSITY HOSPITAL   (Norway)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Cognitive impairment; Memantine; SLE

Indexed keywords

ANTIBODY; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2 ANTIBODY; PLACEBO; UNCLASSIFIED DRUG;

ADULT; AMERICAN COLLEGE OF RHEUMATOLOGY NEUROPSYCHOLOGICAL BATTERY; ARTICLE; AUTOMATED NEUROPSYCHOLOGICAL ASSESSMENT METRICS; COGNITIVE DEFECT; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL PERFORMANCE; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; AGED; COGNITION DISORDERS; DOUBLE-BLIND METHOD; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MEMANTINE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; TREATMENT OUTCOME;

EID: 80755188988     PISSN: 00490172     EISSN: 1532866X     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2011.02.005     Document Type: Article

References (45)

1. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndrome. Arthritis Rheum 1999, 42:599-608. ACR ad hoc committee on neuropsychiatric lupus.
2. Hanson V.G., Horowitz M., Rosenbluth D., Spiera H., Puszkin S. Systemic lupus erythematosus patients with central nervous system involvement show autoantibodies to a 50kd neuronal membrane protein. J Exp Med 1992, 176:565-573.
3. Futrell N., Schultz L.R., Millikan C. Central nervous system disease in patients with systemic lupus erythematosus. Neurology 1992, 42:1649-1657.
4. Kael A.T., Shetty M., Lee B.C.P., Lockshin M.D. The diversity of neurologic events in systemic lupus erythematosus. Prospective clinical classification and computed tomographic or 82 events in 71 patients. Arch Neurol 1986, 43:273-276.
5. McNicholl J., Glynn D., Mongey A., Hutchinson M., Bresnihan B. A prospective study of neurophysiologic, neurologic and immunologic abnormalities in systemic lupus erythematosus. J Rheumatol 1994, 21:1061-1066.
6. West S.G., Emlen W., Wener M.H., Kotzin B.L. Neuropsychiatric lupus erythematosus: a 10-year prospective study on the value of diagnostic tests. Am J Med 1995, 99:153-163.
7. Ainiala H., Hietaharju A., Loukkola J., Peltola J., Korpela M., Metsanoja R., et al. Validity of the new American College of Rheumatology criteria for neuropsychiatric lupus syndromes: a population-based evaluation. Arthritis Care Res 2001, 45:419-423.
8. Brey R.L., Holliday S.L., Saklad A.R., Navarrete M.G., Hermosillo-Romo D., Stallworth C.L. Neuropsychiatric syndromes in SLE: Prevalence using standardized definitions. Neurology 2002, 58(8):1214-1220.
9. Leritz E., Brandt J., Minor M., Reis-Jensen F., Petri M. "Subcortical" cognitive impairment in patients with systemic lupus erythematosus. J Int Neuropsychol Soc 2000, 6(7):821-825.
10. McLaurin E.Y., Holliday S.L., Williams P., Brey R.L. Predictors of cognitive dysfunction in patients with systemic lupus erythematosus. Neurology 2005, 64:297-303.
11. Hanly J.G., Hong C., Smith S., Fisk J.D. A prospective analysis of cognitive function and anticardiolipin antibodies in systemic lupus erythematosus. Arthritis Rheum 1999, 42(4):728-734.
12. Menon S., Jameson-Shortall E., Newman S.P., Hall-Craggs M.R., Chinn R., Isenberg D.A. A longitudinal study of anticardiolipin antibody levels and cognitive functioning in systemic lupus erythematosus. Arthritis Rheum 1999, 42(4):735-741.
13. Denburg S.D., Carbotte R.M., Ginsberg J.S., Denburg J.A. The relationship of antiphospholipid antibodies to cognitive function in patients with systemic lupus erythematosus. J Int Neuropsychol Soc 1997, 3:377-386.
14. Afeltra A., Garzia P., Mitterhofer A.P., Vadacca M., Galluzzo S., Del Porto F. Neuropsychiatric lupus syndromes: relationship with antiphospholipid antibodies. Neurology 2003, 61:108-110.
15. Hanly J.G., Walsh N.M., Fisk J.D., Eastwood B., Hong C., Sherwood G. Cognitive impairment and autoantibodies in systemic lupus erythematosus. Br J Rheumatol 1993, 32:291-296.
16. Faust T.W.E., Change E.H., Kowal C., Berlin R., Gazaryan I.G., Bertini E., et al. Neurotoxic lupus autoantibodies alter brain function through two distinct mechanisms. Proc Natl Acad Sci USA 2010, 107:18549-18574.
17. DeGiorgio L.A., Konstantinov K.N., Lee S.C., Hardin J.A., Volpe B.T., Diamond B. A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat Med 2001, 7:1189-1193.
18. Huerta P.T., Kowal C., DeGiorgio L.A., Volpe B.T., Diamond B. Immunity and behavior: antibodies alter emotion. Proc Natl Acad Sci USA 2006, 103:678-683.
19. Hanly J.G., Robichaud J., Fisk J.D. Anti-NR2 glutamate receptor antibodies and cognitive function in systemic lupus erythematosus. J Rheumatol 2006, 33(8):1553-1558.
20. Harrison M.J., Ravdin L.D., Lockshin M.D. Relationship between serum NR2a antibodies and Cognitive dysfunction in systemic lupus erythematosus. Arthritis Rheum 2006, 54(8):2515-2522.
21. Lapteva L., Nowak M., Yarboro C., Takada K., Roebuck-Spencer T., Weickert T., et al. Anti-N-methyl-D-asparate receptor antibodies, cognitive dysfunction, and depression in systemic lupus erythematosus. Arthritis Rheum 2006, 54(8):2505-2514.
22. Omdal R., Brokstad K., Waterloo K., Koldingsnes W., Jonsson R., Mellgren S.I. Neuropsychiatric disturbances in SLE are associated with antibodies against NMDA receptors. Eur J Neurol 2005, 12:392-398.
23. Tariot P.N., Farlow M.R., Grossberg G.T., Graham S.M., McDonald S., Gergel I. Memantine treatment in patients with moderate to severe Alzheimer Disease already receiving donepezil: a randomized controlled trial. JAMA 2004, 291:317-324.
24. Winblad B., Poritis N. Memantine in severe dementia: results of the 9M-BEST study (benefit and efficacy in severely demented patients during treatment with memantine). Int J Geriatr Psychiatry 1999, 14:135-146.
25. Reisberg B., Doody R., Stoffler A., Schmitt F., Ferris S., Mobius H.J. Memantine in moderate-to-severe Alzheimer's disease. N Engl J Med 2003, 348(14):1333-1341.
26. Gauthier S., Scheltens P. Can we do better in developing new drugs for Alzheimer's disease?. Alzheimers Dement 2009, 5:489-491.
27. Mosca M., Tani C., Aringer M., Bombardieri S., Boumpas D., Brey R., et al. Development of recommendations for monitoring systemic lupus erythematosus patients in clinical practice and in observational studies. Arthrits Rheum 2011, (in press).
28. Bertsias G., Ioannidis J.P.A., Boletis J., Bombardieri S., Cervera R., Dostal C., et al. EULAR recommendations for the management of systemic lupus erythematosus. Report of a task for the EULAR standing committee for international clinical studies including therapeutics. Ann Rheum Dis 2008, 67:195-205.
29. Petri M., Kim M.Y., Kalunian K.C., Grossman J., Hahn B.H., Sammaritano L.R., et al. Combined oral contraceptives in women with systemic lupus erythematosus. N Engl J Med 2005, 353(24):2550-2558.
30. Reeves D., Bleiberg J., Spector J. Validation of the ANAM Battery in multi-center head injury studies. Arch Clin Neuropsychol 1993, 8:356.
31. Bleiberg J., Kane R.L., Reeves D.L., Garmoe W.S., Halpern E.L. Factor analysis of computerized and traditional tests used in mild brain injury research. Clin Neuropsychol 2000, 14:287-294.
32. Roebuck-Spencer T.M., Yarboro C., Nowak M., Takada K., Jacobs G., Lapteva L., et al. Use of computerized assessment to predict neuropsychological functioning and emotional distress in patients with systemic lupus erythematosus. Arthritis Rheum 2006, 55:434-441.
33. Hanly J.G., Omisade A., Su L., Farewell V., Fisk J.D. Assessment of cognitive function in systemic lupus erythematosus, rheumatoid arthritis, and multiple sclerosis by computerized neuropsychological tests. Arthritis Rheum 2010, 62:1478-1486.
34. Woodcock R.W., Munoz-Sandoval A.F. Woodcock-Munoz Language Survey. Comprehensive manual 1993, The Riverside Publishing Company, Itasca (IL).
35. Spreen O., Strauss E. A compendium of neuropsychological tests 1991, Oxford University Press, New York.
36. Meyers J.E., Meyers K.R. Rey Complex Figure Test and Recognition Trial. Professional Manual 1995, Psychological Assessment Resources, Odessa (FL).
37. Fridlund A.J., Delis D.C. California Verbal learning Test, Adult Version 1.2 1987, The Psychological Corporation, San Antonio (TX).
38. Wechsler D. Wechsler Adult Intelligence Scale-Third Edition. Administration and Scoring Manual 1997, The Psychological Corporation, San Antonio (TX).
39. Putterman C., Diamond B. Immunization with a peptide surrogate for double- stranded DNA (dsDNA) induces autoantibody production and renal immunoglobulin deposition. J Exp Med 1998, 1:29-38.
40. Wang B., Gladman D.D., Urowitz M.B. Fatigue in lupus is not correlated with disease activity. J Rheumatol 1998, 25:892-895.
41. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960, 23:56-62.
42. Folstein M.F., Folstein S.E., McHugh P.R. "Mini mental state." A practical method for grading the cognitive state of patients for the clinician. J Psychiatry Res 1975, 12:189-198.
43. Naqibuddin M., Wallace D.J., Weisman M.H., Holliday S.L., Wing N.F., Brey R.L., et al. Cognitive functioning in recently-diagnosed systemic lupus erythematosus. Arthritis Rheum 2004, 50(9):S195.
44. Petri M., Naqibuddin M., Carson K.A., Sampedro M., Wallace D.J., Weisman M.H., et al. Cognitive function in a systemic lupus erythematosus inception cohort. J Rheumatol 2008, 35(9):1776-1781.
45. Petri M., Naqibuddin M., Carson K.A., Wallace D.J., Weisman M.H., Holliday S.L., et al. Depression and cognitive impairment in newly diagnosed systemic lupus erythematosus. J Rheumatol 2010, 37(10):2032-2038.